Acetic Acid → HCID 58346709, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([NH:17][C:18]2[N:19]=[CH:20][N:21]=[C:22]3[S:39][C:25]4[C:26]5[C:30]([CH2:31][CH2:32][C:24]=4[C:23]=23)=[N:29][N:28]([CH:33]2[CH2:38][CH2:37][NH:36][CH2:35][CH2:34]2)[CH:27]=5)[CH:5]=[CH:6][C:7]=1[O:8][CH2:9][C:10]1[CH:15]=[CH:14][CH:13]=[C:12]([F:16])[CH:11]=1.[CH3:40][C:41]([CH3:43])=O.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].C(O)(=O)C>C1COCC1>[Cl:1][C:2]1[CH:3]=[C:4]([NH:17][C:18]2[N:19]=[CH:20][N:21]=[C:22]3[S:39][C:25]4[C:26]5[C:30]([CH2:31][CH2:32][C:24]=4[C:23]=23)=[N:29][N:28]([CH:33]2[CH2:38][CH2:37][N:36]([CH:41]([CH3:43])[CH3:40])[CH2:35][CH2:34]2)[CH:27]=5)[CH:5]=[CH:6][C:7]=1[O:8][CH2:9][C:10]1[CH:15]=[CH:14][CH:13]=[C:12]([F:16])[CH:11]=1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-2-piperidin-4-yl-4,5-dihydro-2H-pyrimido[5′,4′:4,5]thieno[2,3-e]indazol-6-amine (40 mg, 0.07 mmol, 1 eq) in THF (1 mL) was added acetone (8 mg, 0.14 mmol, 2 eq), sodium triacetoxyborohydride (23 mg, 0.11 mmol, 1.5 eq) and trace amount of acetic acid. It was stirred at rt for 16 h. The mixture was purified by preparative HPLC to yield the desired product (15.4 mg, 36%). 1H-NMR (DMSO-d6) δ 8.41 (broad, 1H), 8.32 (d, 1H), 8.01 (d, 1H), 7.74 (d, 1H), 7.5 (dd, 1H), 7.44 (m, 1H), 7.29 (m, 2H), 7.20 (d, 1H), 7.15 (m, 1H), 5.24 (s, 2H), 4.04 (m, 1H), 3.36 (m, 4H), 2.92 (m, 3H), 2.74 (m, 1H), 2.25 (m, 1H), 2.02 (m, 2H), 1.89 (m, 2H), 0.99 (d, 6H). LCMS RT=2.87 min; [M+H]+=603.2.
Workup
- customThe mixture was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-6f955b6b5cac45a094f5f2b209346ca7
- Source dataset
- uspto-grants-2012_06
- Patent number
- US08207172B2
Reaction notes
Loading…